| Literature DB >> 28837605 |
Marcelina Mazur1, Witold Gładkowski1, Višnja Gaurina Srček2, Kristina Radošević2, Gabriela Maciejewska3, Czesław Wawrzeńczyk1.
Abstract
Three β-cyclocitral-derived halolactones, which exhibit antifeedant activity towards storage product pests, were subjected to microbial transformation processes. Among the thirty tested strains of filamentous fungi and yeast, the most effective biocatalysts were Absidia cylindrospora AM336, Mortierella isabellina AM212 and Mortierella vinaceae AM149. As a result of regio- and enantioselective hydroxylation four new oxygenated derivatives were obtained. Regardless of the biocatalyst applied, the δ-iodo- and δ-bromo-γ-lactones were hydroxylated in an inactivated position C-5 of cyclohexane ring. The analogous transformation of chlorolactone was observed in Mortierella isabellina AM212 culture but in the case of two other biocatalysts the hydroxy group was introduced at C-3 position. All obtained hydroxylactones were enantiomerically pure (ee = 100%) or enriched (ee = 50%). The highest enantioselectivity of hydroxylation was observed for M. isabellina AM212. The cytotoxic activity of halolactones was also examined by WST-1 assay wherein tested compounds did not exhibit significant effect on the viability of tumor HeLa and normal CHO-K1 cells.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28837605 PMCID: PMC5570294 DOI: 10.1371/journal.pone.0183429
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
The composition (in % according to GC) of the products mixtures in the screening biotransformations of halolactones 1, 2 and 3.
| Time of incubation | ||||||
| 1 | 100 | 0 | 57 | 43 | 49 | 51 |
| 2 | 100 | 0 | 44 | 56 | 32 | 68 |
| 3 | 74 | 26 | 36 | 64 | 18 | 82 |
| 6 | 59 | 41 | 21 | 79 | 0 | 100 |
| 9 | 46 | 54 | 13 | 87 | 0 | 100 |
| 12 | 23 | 77 | 4 | 96 | 0 | 100 |
| 15 | 18 | 82 | 0 | 100 | 0 | 100 |
| 1 | 100 | 0 | 89 | 11 | 52 | 48 |
| 2 | 91 | 9 | 63 | 37 | 23 | 77 |
| 3 | 79 | 21 | 34 | 66 | 17 | 83 |
| 6 | 62 | 38 | 18 | 82 | 6 | 94 |
| 9 | 42 | 58 | 11 | 89 | 3 | 97 |
| 12 | 22 | 78 | 0 | 100 | 0 | 100 |
| 15 | 14 | 86 | 0 | 100 | 0 | 100 |
| 1 | 98 | 2 | 65 | 35 | 79 | 21 |
| 2 | 91 | 9 | 54 | 46 | 51 | 49 |
| 3 | 85 | 15 | 39 | 61 | 25 | 75 |
| 6 | 69 | 31 | 22 | 78 | 3 | 97 |
| 9 | 42 | 58 | 6 | 94 | 0 | 100 |
| 12 | 27 | 73 | 0 | 100 | 0 | 100 |
| 15 | 13 | 87 | 0 | 100 | 0 | 100 |
The enantiomeric excess (ee %) of obtained biotransformation products.
| Strain | Product | Ee | Product | ee | Product | ee |
|---|---|---|---|---|---|---|
| 50% | 76% | 52% | ||||
| 100% | 95% | 66% | ||||
| 90% | 91% | 67% |
Effect of halolactones (1, 2, 3) on HeLa and CHO cell viability, determined by the WST-I assay.
The viability (%) was expressed as percentage of treated cells versus control cells.
| Compound | Concentration | |||
|---|---|---|---|---|
| HeLa | CHO-K1 | |||
| 100μM | 200μM | 100μM | 200μM | |
| 98.89±5.58 | 87.50±3.54 | 97.08±10.61 | 100.85±1.92 | |
| 97.69±1.78 | 90.13±4.00 | 100.08±6.82 | 100.85±7.29 | |
| 97.05±2.65 | 92.66±4.96 | 97.19±3.48 | 102.77±3.80 | |